2-31074658-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024572.4(GALNT14):c.129+63300A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.628 in 151,796 control chromosomes in the GnomAD database, including 31,177 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.63 ( 31177 hom., cov: 30)
Consequence
GALNT14
NM_024572.4 intron
NM_024572.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.283
Publications
5 publications found
Genes affected
GALNT14 (HGNC:22946): (polypeptide N-acetylgalactosaminyltransferase 14) This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Alterations in this gene may play a role in cancer progression and response to chemotherapy. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.817 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GALNT14 | NM_024572.4 | c.129+63300A>C | intron_variant | Intron 1 of 14 | ENST00000349752.10 | NP_078848.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GALNT14 | ENST00000349752.10 | c.129+63300A>C | intron_variant | Intron 1 of 14 | 1 | NM_024572.4 | ENSP00000288988.6 |
Frequencies
GnomAD3 genomes AF: 0.627 AC: 95175AN: 151678Hom.: 31125 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
95175
AN:
151678
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.628 AC: 95278AN: 151796Hom.: 31177 Cov.: 30 AF XY: 0.622 AC XY: 46110AN XY: 74162 show subpopulations
GnomAD4 genome
AF:
AC:
95278
AN:
151796
Hom.:
Cov.:
30
AF XY:
AC XY:
46110
AN XY:
74162
show subpopulations
African (AFR)
AF:
AC:
34161
AN:
41424
American (AMR)
AF:
AC:
9502
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1704
AN:
3462
East Asian (EAS)
AF:
AC:
2362
AN:
5138
South Asian (SAS)
AF:
AC:
2372
AN:
4790
European-Finnish (FIN)
AF:
AC:
5516
AN:
10506
Middle Eastern (MID)
AF:
AC:
188
AN:
292
European-Non Finnish (NFE)
AF:
AC:
37726
AN:
67898
Other (OTH)
AF:
AC:
1212
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1693
3386
5078
6771
8464
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1716
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.